S. Duggineni

发表

Application of modified Pictet–Spengler reaction for the synthesis of thiazolo- and pyrazolo-quinolines

B. Kundu, B. Saha, Devesh M. Sawant, 2006 .

A synthetic bivalent ligand of CXCR4 inhibits HIV infection.

D. Richman, J. An, Ziwei Huang, 2013, Biochemical and biophysical research communications.

Discovery and Characterization of a Novel Cyclic Peptide That Effectively Inhibits Ephrin Binding to the EphA4 Receptor and Displays Anti-Angiogenesis Activity

J. An, Ziwei Huang, Xiaofeng Han, 2013, PloS one.

Development of a Novel Fluorescence Polarization–Based Assay for Studying the β-Catenin/Tcf4 Interaction

Xiaobin Han, J. An, Ziwei Huang, 2012, Journal of biomolecular screening.

ARTS and Siah collaborate in a pathway for XIAP degradation.

J. B. Garrison, John Calvin Reed, K. Welsh, 2011, Molecular cell.

Structure-activity relationship analysis of peptides targeting the EphA2 receptor.

E. Pasquale, Ziwei Huang, Xuejun Zhu, 2010, Biochemistry.

Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor.

E. Pasquale, J. An, Ziwei Huang, 2013, ACS medicinal chemistry letters.

Solid phase synthesis of quinoxalines

S. Singh, B. Kundu, Priya Gupta, 2003 .

Solid-phase synthesis of 2-aminoquinazolinone derivatives with two- and three-point diversity.

B. Kundu, Devesh M. Sawant, S. Duggineni, 2005, Journal of combinatorial chemistry.

Application of Modified Pictet—Spengler Reaction for the Synthesis of Thiazolo- and Pyrazolo-quinolines.

B. Kundu, B. Saha, Devesh M. Sawant, 2006 .

Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.

N. Lin, Xiaobin Han, J. An, 2012, Biochemistry.

Chemical mutagenesis of a GPCR ligand: Detoxifying “inflammo-attraction” to direct therapeutic stem cell migration

R. Sidman, Yinsong Zhu, E. Snyder, 2020, Proceedings of the National Academy of Sciences.

Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Won-Tak Choi, Won-Tak Choi, J. An, 2012, Journal of medicinal chemistry.

A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry.

J. Sodroski, Won-Tak Choi, C. Dong, 2012, Biochemistry.

Pictet-Spengler Synthesis of Thiazolo- and Pyrazolo-quinolines

B. Kundu, B. Saha, Devesh M. Sawant, 2006 .

Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Won-Tak Choi, J. An, Ziwei Huang, 2011, Journal of medicinal chemistry.

A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.

P. Shukla, B. Kundu, A. K. Chaturvedi, 2007, International journal of antimicrobial agents.

Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.

N. Lin, R. Noberini, E. Pasquale, 2013, Biochemical pharmacology.

PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity

N. Prigozhina, R. Noberini, E. Pasquale, 2011, PloS one.

ARTS and Siah collaborate in a pathway for XIAP degradation.

J. B. Garrison, John Calvin Reed, K. Welsh, 2011, Molecular cell.